Prevaelnce of different pathogens by location. by Amete Mihret Teshale (12072758)

“…<div><p>Diarrheal illness remains a major global health challenge, causing millions of deaths annually. …”

Shaping the task allows the network to adapt to a large rotation angle (here ) even if the target size and the noise level are extremely small. by Ran Darshan (507608)

“…<p><b>A.</b> Shaping by decreasing the target size, as explained in the text. …”

Effects of ROS scavenging on the counteraction of EMT-like process due to <i>K</i>. <i>pneumoniae</i> infection of A549 cells. by Laura Leone (297477)

“…<p>The A549 cells were pretreated for 12h before the infection with the resveratrol 50 μM. …”

Table_2_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”

Table_6_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”

Table_1_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”

Table_5_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”

Table_3_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOC by Guangzhi Hao (13836529)

“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”

Table_4_Clinical effectiveness of nimodipine for the prevention of poor outcome after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.DOCX by Guangzhi Hao (13836529)

“…Remarkably, we found a poor outcome and mortality were both significantly lower among patients with aSAH, with the mean age < 50 than that mean age ≥ 50 by subgroup analysis. …”

Table_1_Magnetic Non-invasive Auricular Acupuncture During Eye-Exam for Retinopathy of Prematurity in Preterm Infants: A Multicentre Randomized Controlled Trial.DOC by Kimberly M. L. Gan (9912195)

“…We hypothesized that magnetic auricular acupuncture (MAA) compared to placebo will decrease pain during ROP exam in preterm infants.…”

Image2_Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions.pdf by Maja Đanić (14589095)

Image1_Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions.pdf by Maja Đanić (14589095)

Image3_Bioaccumulation and biotransformation of simvastatin in probiotic bacteria: A step towards better understanding of drug-bile acids-microbiome interactions.pdf by Maja Đanić (14589095)

Beluga-Halibut-Si-Data from Temporal shifts in intraguild predation pressure between beluga whales and Greenland halibut in a changing Arctic. by David J. Yurkowskil (4556449)

A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated Lipodystrophy by Alka Deshpande (847076)

“…</p><p>Results</p><p>Saroglitazar 4 mg significantly decreased the serum TG levels from baseline at Week 6 (percent change: -40.98; 95% CI: -50.82, -31.15) and Week 12 (percent change -45.11; 95% CI: -52.37, -37.86). …”

Clinical and Prognostic Significance of HIF-1α, PTEN, CD44v6, and Survivin for Gastric Cancer: A Meta-Analysis by Jing Chen (4762)

Data Sheet 1_The effect of Traditional Chinese Medicine on patients undergoing targeted therapy for primary liver cancer: a systematic review and meta-analysis.docx by Hongting Yan (13242201)

“…Objective<p>Evaluate the therapeutic efficacy and safety of Traditional Chinese Medicine (TCM) in patients with primary liver cancer (PLC) receiving targeted therapy.</p>Methods<p>We conducted a comprehensive search of databases. …”

Table1_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.DOCX by Zehua Zhang (312656)

“…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”

Table2_The efficacy and safety of dachaihu decoction in the treatment of type 2 diabetes mellitus: A systematic review and meta-analysis.DOCX by Zehua Zhang (312656)

“…<p>Background: Type 2 diabetes mellitus (T2DM) is a clinical metabolic syndrome characterized by persistent hyperglycemia, which is caused by defective insulin secretion and decreased function in regulating glucose metabolism. …”

Supplementary Material for: Acute Ischemic Stroke (AIS) Patient Management in French Stroke Units and Impact Estimation of Thrombolysis on Care Pathways and Associated Costs by Schmidt A. (3231942)

“…By increasing the proportion of patients being thrombolyzed, costs are reduced primarily by a decrease in rehabilitative care, with savings per additional treated patient of €1,462. …”